Poor medication adherence is a pervasive issue with considerable health and
socioeconomic consequences. Although the underlying reasons are generally understood …

Microneedle arrays (MNAs) are small patches containing hundreds of short projections that
deliver signals directly to dermal layers without causing pain. These technologies are of …

Objective To develop recommendations for disease-modifying therapy (DMT) for multiple
sclerosis (MS). Methods A multidisciplinary panel developed DMT recommendations …

Background: Most disease‐modifying therapies (DMTs) for multiple sclerosis (MS) are self‐
injectable medications that must be taken on an ongoing basis to reduce disease activity …

People with multiple sclerosis (MS) face challenges adhering to disease-modifying drug
(DMD) treatment. Poor adherence to treatment reduces its clinical effectiveness which can …

Multiple sclerosis (MS) is a chronic autoimmune disease that impacts the central nervous
system and can result in disability. Although the prevalence of MS has increased in India …

While no curative treatment exists for multiple sclerosis (MS), several disease-modifying
therapies (DMTs) have been developed to reduce relapse rates, slow disability progression …

Background Adherence to disease-modifying therapies (DMTs) is essential for the reduction
of multiple sclerosis (MS) progression and relapse. However, only limited data currently exist …

Background: Relapsing-remitting multiple sclerosis (RRMS) is a chronic disease affecting
about 400 000 people in the US characterized by increasing patient disability and burden on …

While advances in medicine, technology and healthcare services offer promises of longevity
and improved quality of life (QoL), there is also increasing reliance on a patient׳ s skills and …